Alban Bornet

Boya Zhang, Alban Bornet, Rui Yang et al.

How do language models use contextual information to answer health questions? How are their responses impacted by conflicting contexts? We assess the ability of language models to reason over long, conflicting biomedical contexts using HealthContradict, an expert-verified dataset comprising 920 unique instances, each consisting of a health-related question, a factual answer supported by scientific evidence, and two documents presenting contradictory stances. We consider several prompt settings, including correct, incorrect or contradictory context, and measure their impact on model outputs. Compared to existing medical question-answering evaluation benchmarks, HealthContradict provides greater distinctions of language models' contextual reasoning capabilities. Our experiments show that the strength of fine-tuned biomedical language models lies not only in their parametric knowledge from pretraining, but also in their ability to exploit correct context while resisting incorrect context.

Anthony Yazdani, Alban Bornet, Philipp Khlebnikov et al.

Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encompasses 2,497 drugs and 168,984 drug-ADE pairs from clinical trial results, annotated using the MedDRA ontology. Unlike existing resources, CT-ADE integrates treatment and target population data, enabling comparative analyses under varying conditions, such as dosage, administration route, and demographics. In addition, CT-ADE systematically collects all ADEs in the study population, including positive and negative cases. To provide a baseline for ADE prediction performance using the CT-ADE dataset, we conducted analyses using large language models (LLMs). The best LLM achieved an F1-score of 56%, with models incorporating treatment and patient information outperforming by 21%-38% those relying solely on the chemical structure. These findings underscore the importance of contextual information in ADE prediction and establish CT-ADE as a robust resource for safety risk assessment in pharmaceutical research and development.